Co-Diagnostics, Inc. (LON:0A50)

Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of GBP 8.37 million. The enterprise value is 973,697.

Market Cap	8.37M
Enterprise Value	973,697

Important Dates

The next estimated earnings date is Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.03M
Shares Outstanding	n/a
Shares Change (YoY)	+11.72%
Shares Change (QoQ)	+14.45%
Owned by Insiders (%)	5.08%
Owned by Institutions (%)	12.38%
Float	1.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.14
PB Ratio	0.28
P/TBV Ratio	0.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.04
EV / Sales	2.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.04

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.04.

Current Ratio	3.81
Quick Ratio	3.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.12% and return on invested capital (ROIC) is -41.33%.

Return on Equity (ROE)	-62.12%
Return on Assets (ROA)	-37.92%
Return on Invested Capital (ROIC)	-41.33%
Return on Capital Employed (ROCE)	-86.56%
Revenue Per Employee	2,862
Profits Per Employee	-181,371
Employee Count	132
Asset Turnover	0.01
Inventory Turnover	0.28

Taxes

Income Tax	-855,856
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-75.24%
50-Day Moving Average	10.89
200-Day Moving Average	10.09
Relative Strength Index (RSI)	28.53
Average Volume (20 Days)	2,528

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.03

Income Statement

In the last 12 months, Co-Diagnostics had revenue of GBP 377,841 and -23.94 million in losses. Loss per share was -21.58.

Revenue	377,841
Gross Profit	128,585
Operating Income	-26.43M
Pretax Income	-24.80M
Net Income	-23.94M
EBITDA	-25.54M
EBIT	-26.43M
Loss Per Share	-21.58

Balance Sheet

The company has 8.51 million in cash and 1.10 million in debt, giving a net cash position of 7.42 million.

Cash & Cash Equivalents	8.51M
Total Debt	1.10M
Net Cash	7.42M
Net Cash Per Share	n/a
Equity (Book Value)	29.63M
Book Value Per Share	18.46
Working Capital	7.71M

Cash Flow

In the last 12 months, operating cash flow was -23.19 million and capital expenditures -476,914, giving a free cash flow of -23.66 million.

Operating Cash Flow	-23.19M
Capital Expenditures	-476,914
Free Cash Flow	-23.66M
FCF Per Share	n/a

Margins

Gross Margin	34.03%
Operating Margin	-6,995.70%
Pretax Margin	-6,562.78%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.72%
Shareholder Yield	-11.72%
Earnings Yield	-286.19%
FCF Yield	-282.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Co-Diagnostics has an Altman Z-Score of -1.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.69
Piotroski F-Score	1